Posted Jun 19th 2009 4:40PM by Melly Alazraki
Filed under: Pfizer (PFE), Ford Motor (F), Home Depot (HD), Diageo plc (DEO), Best Buy (BBY), Lilly (Eli) (LLY), Harley-Davidson (HOG), Stocks to Buy
Every year I find myself asking the same question: What to get dad for Father's Day. Well, Kiplinger's offers not to get our dads the same old presents -- another tie, another power tool -- but
stocks in companies he probably likes or uses their products. That's a great idea, I thought, and decided to counter with five of my own.
- Kiplinger's suggests: Diageo (NYSE: DEO), the seller of such brands as Johnnie Walker, Smirnoff, Guinness and José Cuervo. Diageo has held up better than most during the recession -- thanks to a balanced portfolio of products, with higher exposure to mid-price, mainstream brands and less exposure to ultra-premium brands. The shares look reasonably priced. At $56.01, Diageo trades at 15 times estimated June 2009 earnings of $3.82 a share. The stock yields 2.8%.
- Another to consider: Molson Coors (NYSE: TAP), the seller of such brands as Coors, Blue Moon, Pilsner and Rickard's. Beer, probably even more so than hard liquor is supposed to hold better during a recession given the cheaper price point. The company's recent quarterly profits more than doubled. The shares trade at 13 times forward earnings of $3.33 and yield 2.2%.
Continue reading Five stocks for Father's Day from Kiplinger's ... and five more
Posted Jun 16th 2009 10:00AM by Jim Cramer
Filed under: Market matters, Lilly (Eli) (LLY), Cramer on BloggingStocks
TheStreet.com's Jim Cramer says there'll be a time to buy health care. But wait until the smoke clears. Please don't tell me we are back in the world of no institutional memory again. That all that happened is we dropped enough points to freak everyone out, get the bears out of hibernation and then it is onward and upward. Nothing would shock me, especially the vehemence with which everyone hated the market again Monday.
If you replay what happened, most of the issues stemmed from statements made by the same Europeans that have said no more stimulus is needed, the same Europeans who have been in denial the whole way publicly, but believe me they have been stimulating like mad because their banks are a much larger size relative to their gross domestic product than ours and are in many ways worse off.
Continue reading Cramer on BloggingStocks: Don't fight the Obama phalanx
Posted Jun 8th 2009 6:00PM by Joseph Lazzaro
Filed under: Lilly (Eli) (LLY), Stocks to Buy
Readers of this space know that the investment bias is toward large-cap companies with demonstrated business models and who have a competitive advantage in established markets, preferably with a favorable, global trend as a support. And with the aforementioned in mind,
Eli Lilly & Co. (NYSE:
LLY) is worth a review.
In general, analysts see a 5-7% revenue gain in FY2009 for Lilly, led by growth in sales of branded drugs Cymbalta, Humalog, Cialis, and Alimta. Meanwhile, sales of Zyprexa and Gemzar are likely to decline this year.
Continue reading Time to scoop up some shares of Lilly
Posted May 4th 2009 10:00AM by Jim Cramer
Filed under: PepsiCo (PEP), Market matters, Caterpillar (CAT), Abbott Laboratories (ABT), Kellogg Co (K), Clorox Co (CLX), Colgate-Palmolive (CL), Hershey Co (HSY), General Mills (GIS), Kimberly-Clark (KMB), Lilly (Eli) (LLY), Freep't McMoRan Copper (FCX), Cramer on BloggingStocks
TheStreet.com's Jim Cramer suggests watching certain staples for hints that the flight to riskier plays is losing steam. Will the endless "beta" trade out of slow-moving, "safe" drugs and foods and into companies like
Freeport-McMoRan (NYSE:
FCX) (
Cramer's Take) and
Caterpillar (NYSE:
CAT) (
Cramer's Take) ever end?
I think it won't end here, that's for certain, unless your staples stock goes to a 5% yield and the economy's macro data show a further breakdown. If we get some retail sales that are awful and some employment numbers that show a further trashing, then we are going to see a momentary blip up in stocks like
Pepsi (NYSE:
PEP) (
Cramer's Take) and
Clorox (NYSE:
CLX) (
Cramer's Take), but perhaps no more than that.
Continue reading Cramer on BloggingStocks: 'Tells' of the beta trade
Posted Feb 25th 2009 8:56AM by Allan Halprin
Filed under: Microsoft (MSFT), Yahoo! (YHOO), General Electric (GE), Citigroup Inc. (C), Johnson and Johnson (JNJ), JPMorgan Chase (JPM), Money and Finance Today, Abbott Laboratories (ABT), AFLAC Inc (AFL), American Express (AXP), Bristol-Myers Squibb (BMY), Consolidated Edison (ED), Verizon Communications (VZ), News Corp'B' (NWS), UAL Corp (UAUA), Lilly (Eli) (LLY)
Continue reading 5% dividends you can believe in, is your pension safe? & 9 optimistic people - Today in Money 2/25
Posted Jan 29th 2009 3:15PM by Mark Fightmaster
Filed under: Earnings reports, Lilly (Eli) (LLY)
Earlier today, pharmaceutical firm Eli Lilly (NYSE: LLY) announced that it suffered a fourth-quarter loss thanks to charges suffered when purchasing ImClone Systems. Excluding these charges, LLY tallied $1.07 per share in the quarter -- topping analysts' estimates for $1.05 per share. Taking the ImClone acquisition (which cost LLY $4.73 billion in charges) into account, LLY lost $3.31 per share during the quarter. Quarterly revenue checked in at $5.42 billion.
Continue reading Eli Lilly posts quarterly earnings
Posted Jan 29th 2009 8:18AM by Melly Alazraki
Filed under: Earnings reports, Starbucks (SBUX), Amazon.com (AMZN), Ford Motor (F), 3M Corporation (MMM), Allstate Corp (ALL), Altria Group (MO), QUALCOMM Inc (QCOM), Lilly (Eli) (LLY), Wells Fargo (WFC)
Ford Motor Co. (NYSE: F) posted a
loss of $5.9 billion, or $2.46 per share, in the fourth quarter, but it said that it still has no plans to seek federal aid unless economic conditions worsen. Ford burned through $5.5 billion in cash during the quarter. Excluding one-time items, Ford lost $1.37 per share, below estimates of a loss of $1.30 per share. Revenue fell to $29.2 billion, down from $45.5 billion for the fourth quarter of 2007. Ford's shares are gaining nearly 2.5% in premarket trading.
Fifteen minutes after the open, Ford shares were 2.2% lower.
Starbucks (NASDAQ: SBUX) reported worse-than-expected quarterly results late Wednesday after the close, as its quarterly profit dropped 69%. It also also announced 6,700 more job cuts and plans to close 300 stores. As the company has been hurt by tighter consumer spending, it said it will not provide any sales or earnings guidance. SBUX shares are defclining over 4% in premarket trading. Fifteen minutes after the open, SBUX shares were flattish.
Continue reading Stocks in the news: SBUX, F, LLY, MMM, LLY, MO, QCOM, ALL, WFC ...
Posted Jan 15th 2009 9:12AM by Allan Halprin
Filed under: Google (GOOG), Apple Inc (AAPL), Motorola (MOT), JPMorgan Chase (JPM), Kellogg Co (K), Nortel Networks (NT), Lilly (Eli) (LLY), Delta Air Lines (DAL)
c
In the News:
The Biggest Insurance Scheme of All Time?UnitedHealth Group, one of the country's largest insurers, settled what may be one of the largest health insurance schemes of all time on Tuesday after allegedly cheating sick patients out of hundreds of millions of dollars. And it probably would not have happened without Mary Jerome, an advanced-stage ovarian cancer patient who finally just said "enough" after getting hit with $46,000 in medical bills – even though she had top-notch insurance coverage.
http://www.cnbc.com/id/28643259
Continue reading Old fashioned businesses that still make money, 5 easy ways to beat money stress & fame in family - Today in Money 1/15
Posted Jan 15th 2009 8:14AM by Melly Alazraki
Filed under: Earnings reports, Deals, Google (GOOG), Apple Inc (AAPL), Intel (INTC), Motorola (MOT), JPMorgan Chase (JPM), Bank of America (BAC), Genentech Inc (DNA), Lilly (Eli) (LLY)
JPMoragn Chase (NYSE: JPM) has amazingly managed to
surprise Wall Street when it reported its quarterly results this morning. Maybe that's why it decided to report six days early. JPMorgan even managed to avoid a loss in the fourth quarter, perhaps a sign it is managing much better than others during this crisis than other banks. Of course, it wasn't that rosy as its reported profit of $702 million, or 7 cents per share, was down sharply -- 76% -- from $2.97 billion, or 86 cents per share, a year ago. Analysts expected break-even results. Shares were 3% higher in premarket trading.
Apple Inc. (NASDAQ: AAPL) CEO Steve Jobs announced Wednesday after the close he is taking a
medical leave of absence until the end of June. COO Tim Cook will be taking over Jobs' day-to-day operations, but Jobs said he'll still be involved in strategic decisions. When shares resumed trading in after-hours, they were down some 8%. Only last week Jobs said he suffers from a hormone imbalance that caused him to lose weight, but that he will remain CEO during his recovery. This has been quite the reversal that he says is due to his problems being "more complex" than originally thought.
This morning, also, Bloomberg reports that Jobs "could be
facing surgery to remove his pancreas," according to doctors.
Apart from Jobs illness, though, Gartner has released a
preliminary report on U.S. and worldwide PC shipment, which places Apple in fourth place in U.S market share at 8.0% in the fourth quarter, down from
9.5% in the third quarter of 2008.
RBC Capital Mkts downgraded AAPL from Sector Perfrom to Underperform. Oppenheimer lowered its target price from $135 to $120.
AAPL shares were down 7% in premarket trading.
Continue reading Stocks in the news: AAPL, JPM, BAC, GOOG, MOT, LLY, INTC, STX ...
Posted Jan 8th 2009 9:55AM by Jim Cramer
Filed under: Microsoft (MSFT), Yahoo! (YHOO), Market matters, McDonald's (MCD), 3M Corporation (MMM), JPMorgan Chase (JPM), Bristol-Myers Squibb (BMY), General Mills (GIS), Merck and Co (MRK), Lilly (Eli) (LLY), Kraft Foods'A' (KFT), Wells Fargo (WFC), DJIA, Stocks to Buy, Stocks to Sell, Cramer on BloggingStocks
TheStreet.com's Jim Cramer looks at the next six components of the Dow, including a lousy drug company and a winning financial. This is the fourth part of Jim Cramer's series of predictions for the Dow components in 2009. Be sure to read the
first,
second and third
parts.
JPMorgan Chase (NYSE: JPM) (
Cramer's Take): Jamie Dimon is revered, but we are in a tough market for the consumer in 2009, which truly worries me. That said, the stock has been killed by Dimon's own pessimistic projections, and I don't believe they will pan out as badly as he does.
The dividend appears safe, and I believe that the second half of the year will see some lending improvement and merger activity. I see it going back to where it did a huge equity offering at $39 a share, a nice appreciation from this beaten-down level. It's good, but I believe that
Wells Fargo's (NYSE:
WFC) (
Cramer's Take) performance will give it a run for the money.
My one worry here is the purchase of Washington Mutual. This was another deal that looked great when the Resolution Mortgage Trust part of TARP was still alive -- I don't believe that it would have been worth buying Washington Mutual without it. But that's all too late, and now JPMorgan has to rationalize the two entities and cut costs as aggressively as possible, something Jamie Dimon knows to do better than anyone in the banking world ... with the exception of Wells Fargo.
Continue reading Cramer on BloggingStocks: Cramer bullish on the Dow for '09 -- Part IV
Posted Dec 11th 2008 4:20PM by Jon Ogg
Filed under: After the bell, Market matters, Costco Wholesale (COST), Nortel Networks (NT), Lilly (Eli) (LLY)
Stocks fell today as financials were hit hard after a report from UBS predicted
losses in the banking sector again in 2009. Jamie Dimon's
interview comments didn't give any massive confidence boost either. This was the first day that there was a major move to the upside in what feels like forever, as oil was up $3.49 per barrel at $47.01 on last look. Today's weekly jobless claims data was also the worst we have seen in this part of the cycle.
Here are today's closing bell levels:
DJIA: 8,565.09 (-2.24)
S&P 500: 873.58 (-2.85)
NASDAQ: 1,507.88 (-3.68)
52-Week LowsAmylin Pharmaceuticals, Inc. (NASDAQ:
AMLN) announced that the US FDA gave feedback on the DURATION-1 study for once/week diabetes treatment that will allow it to file a new drug application later in the first half of 2009. Shares were up 19% at $10.18 right before the close.
Costco Wholesale Corp. (NASDAQ:
COST) beat earnings with $0.65 EPS vs. $0.62 estimates. Revenues were a tad light. The company said its sales were hurt by a slowdown in non-food discretionary sales and related reductions in margins associated with these sales in the latter half of the quarter.
Continue reading Closing Bell: Stocks slide amid unemployment, banking woes; COST, LULU, NT down, AMLN, LLY gain
Posted Dec 11th 2008 8:15AM by Melly Alazraki
Filed under: Earnings reports, Forecasts, Ford Motor (F), General Motors (GM), Sprint Nextel Corp (S), Costco Wholesale (COST), Procter and Gamble (PG), Amer Intl Group (AIG), Merck and Co (MRK), Lilly (Eli) (LLY)
General Motors Corp. (NYSE: GM),
Ford Motor Co. (NYSE: F) -- The
House finally approved a bill to speed $14 billion in loans to Detroit's automakers. But it still has to pass in the Senate where Republican opposition derail the emergency aid. If the bill passes, Canada will have added pressure to match any assistance for the Big 3. The Swedes have already presented a
$3.4 billion package to help their auto industry. While GM and Chrysler may be
short of time as Senate debates the issue, Ford's previous decision to
leverage assets could be a saving grace as it doesn't need to tap in to the emergency funds ... yet. GM shares are up 1.7% while Ford's down 2.5% in premarket trade.
Both GM and Ford are trading down -- 7.6% and 4.6% respectively by 11 am -- as the Senate debate lingers on.
BCE Inc. (NYSE: BCE) -- what should have been the largest LBO in history is
no longer. The group of buyers terminated the deal Thursday, saying an audit found the proposed $35 billion deal did not meet solvency requirements. As this been all but expected, the stock is down 1.6% in premarket trading (8:04 am).
BCE shares were down 2.6% by 11 am. Costco Wholesale Corp. (NASDAQ: COST) reported on Thursday that fiscal first-quarter
net income rose slightly thanks to strong results from its gas station operations that helped offset weak consumer demand for pretty much everything but the most essential. While it managed to beat estimates, same-store sales were up by only 1%. COST shares were down 1.4% in premarket trade.
COST shares were down 3.2% by 11 am. Continue reading Stocks in the news: GM, F, BCE, COST, S, PG, LLY, MRK, AIG
Posted Oct 23rd 2008 8:11AM by Melly Alazraki
Filed under: Before the bell, Earnings reports, Microsoft (MSFT), Apple Inc (AAPL), Amazon.com (AMZN), Market matters, Sony Corp ADR (SNE), Altria Group (MO), Bristol-Myers Squibb (BMY), Goldman Sachs Group (GS), Xerox Corp (XRX), United Parcel'B' (UPS), Amgen Inc (AMGN), UAL Corp (UAUA), Dow Chemical (DOW), Lilly (Eli) (LLY), Economic data, JetBlue Airways (JBLU)
U.S. stock futures once again were lower this morning, albeit more moderately, pointing to another lower start and possibly another down day following Wednesday's declines. Investors concern over the economy remained unabated, especially in light of recent and future corporate profits. This morning, weekly initial jobless claims will be released an hour ahead of the opening bell, and the numbers are expected to show yet another increase. Meanwhile, investors will continue to eye
oil prices, which rebounded from a 16-month low to above $67, and
foreclosures, which grew by 71% in the third quarter compared with the same period in 2007.
Sony Corp. (NYSE: SNE) drastically
lowered profit and sales forecasts for the fiscal year Thursday, blaming weaker electronics sales and the stronger yen.
Goldman Sachs Group Inc (NYSE: GS) is joining many other companies recently announcing layoffs as it also plans to
cut about 3,260 jobs, representing about 10% of its total staff.
Amazon.com Inc. (NASDAQ: AMZN) reported a
48% climb in profit in the third quarter on strong sales of electronics, beating analyst estimates. But the company reduced its full-year profit outlook. AMZN shares traded down 14% in after-hours action.
Continue reading Before the bell: Set for a lower start; SNE, GS, AMZN, AMGN, DOW, XRX ...
Posted Oct 6th 2008 9:05AM by Allan Halprin
Filed under: eBay (EBAY), Home Depot (HD), Citigroup Inc. (C), Money and Finance Today, Bank of America (BAC), , AMR Corp (AMR), Lilly (Eli) (LLY), Wells Fargo (WFC), ImClone Systems (IMCL)
In the News:
Keeping Customers in a Crummy EconomyWith recession expectations growing, some companies are taking extraordinary steps to hold on to customers. Telephone companies' offers for two months of free service and reduced rates, discounted gym membership renewals, and generous gift cards from high-end department stores all underscore a pervasive fear on Main Street: With the uncertainty around the credit seize-up, consumers may be digging in for a long hibernation.
http://www.businessweek.com/investor/content/oct2008/pi2008103_779103.htm?campaign_id=twxa Why Do Failed CEOs Keep Getting Rehired?Poor stock performance? Weak sales? No matter! If you were once a C.E.O., you can surely be one again. Failed CEOs like Home Depot's Bob Nardelli who ended up at Chrysler and American Airlines' Don Carty who is leading Virgin Atlantic failed CEOs regularly end up at the helm of other companies. Here's why.
http://www.portfolio.com/executives/features/2008/10/05/Why-Failed-CEOs-Get-Rehired Continue reading Recycled CEOs, keeping customers in a crummy economy & 7 money traps to avoid - Today in Money 10/6
Posted Oct 6th 2008 8:13AM by Melly Alazraki
Filed under: Before the bell, International markets, Analyst upgrades and downgrades, Deals, Google (GOOG), Yahoo! (YHOO), Starbucks (SBUX), Coca-Cola (KO), Market matters, Citigroup Inc. (C), Adobe Systems (ADBE), Bank of America (BAC), Bristol-Myers Squibb (BMY), , Lilly (Eli) (LLY), Economic data, Wells Fargo (WFC), ImClone Systems (IMCL)
U.S. stock futures fell Monday morning, indicating a sharply lower open on Wall Street as the world's financial crisis rather than get a boost from the $700 billion rescue plan, seemed to have deepened in Europe. This as well as economic fears
depressed world markets. Most major global markets plunged at least over 4%.
Wachovia Corp. (NYSE:
WB) -- After a lower court decided in favor of Citigroup (NYSE:
C), a state appeals court blocked the ruling late Sunday night, thus tilting the battle over Wachovia in favor of Wells Fargo (NYSE:
WFC). Both banks want Wachovia for its deposits and branches. Despite that, WB shares are down about 18% in pre-market trade, WFC's down 2.7% and C's down 3.7%.
Bank of America (NYSE:
BAC) -- a subsidiary has agreed to modify loans to tens of thousands of borrowers -- previously Countrywide Financial clients -- in 11 states that would enable them to keep their homes, or even help them move to a new home. If all 50 states were to join, the settlement could provide
$8.7 billion in relief to 400,000 borrowers. BAC shares are down 4.3% in pre-market action.
National City Corp. (NYSE:
NCC) shares are down over 22% in pre-market action as its
debt was downgraded by Fitch Ratings.
Continue reading Before the bell: Stocks to plunge; WB, WFC, C, BAC, NCC, LLY, IMCL, KO ...
Next Page »
Comfort Zone Investing: Survival of the fittest -- letting some banks fail
Three All-American stocks for portfolio fireworks
Michael Jackson fireworks, the workaholic
